Covidien EverFlex+ Peripheral Stenting System Released to European Market

Covidien has released its EverFlex+ self-expanding peripheral endovascular stent in Europe. The new version of the stent, third in the series, was designed to improve durability when flexed and elongated, and is available in sizes up to 200mm in length.

The new EverFlex+ system is designed to reduce the risk of fracture when elongated, improving clinical outcomes for patients. The next generation system offers the same customized technology as the current EverFlex system, retaining similar radial strength and flexibility, but adds even more durability. The EverFlex family of products is engineered to provide unmatched durability in a highly flexible platform, representing a significant advance in nitinol self-expanding stent technology.
Durability

Optimized architecture redistributes stress across the stent, reducing “hot spots” that contribute to fracture

During bench testing of elongated stents, the 6 mm EverFlex+ stent ran through nine times more cycles
(average for all diameters was 5.5 more cycles) than EverFlex before showing signs of fracture

Flexibility

Spiral connection design enables uniform shape retention when EverFlex+ is placed in tortuous vessels

Strength

Bench-testing in 6 mm stents revealed no compromise in radial force with EverFlex+ when compared with EverFlex

In other diameters tested, EverFlex+ radial force remained comparable to EverFlex (average was a 2%
increase

Precision

EX.P.R.T. Deployment System holds stent securely in place to prevent premature deployment or
“jumping”

Tantalum GPS markers enhance visibility, enabling precise positioning

Press release: Covidien Unveils Next Generation EverFlex+™ Peripheral Stent System…